Icecure Medical Stock Analysis
ICCM Stock | USD 0.71 0.11 18.33% |
Icecure Medical is undervalued with Real Value of 1.23 and Target Price of 2.91. The main objective of Icecure Medical stock analysis is to determine its intrinsic value, which is an estimate of what Icecure Medical is worth, separate from its market price. There are two main types of Icecure Medical's stock analysis: fundamental analysis and technical analysis.
The Icecure Medical stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Icecure Medical is usually not traded on Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday. Icecure Stock trading window is adjusted to America/New York timezone.
Icecure |
Icecure Stock Analysis Notes
About 54.0% of the company shares are held by company insiders. The book value of Icecure Medical was currently reported as 0.21. The company recorded a loss per share of 0.29. Icecure Medical had not issued any dividends in recent years. The entity had 1:8 split on the 9th of August 2021. IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation of tumors in the human body. The company was incorporated in 2006 and is headquartered in Caesarea, Israel. Icecure Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 55 people. To learn more about Icecure Medical call Eyal Shamir at 972 4 623 0333 or check out https://www.icecure-medical.com.Icecure Medical Quarterly Total Revenue |
|
Icecure Medical Investment Alerts
Icecure Medical had very high historical volatility over the last 90 days | |
Icecure Medical has some characteristics of a very speculative penny stock | |
The company reported the previous year's revenue of 3.23 M. Net Loss for the year was (14.65 M) with profit before overhead, payroll, taxes, and interest of 1.45 M. | |
Icecure Medical currently holds about 17.73 M in cash with (12.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.48. | |
Icecure Medical has a poor financial position based on the latest SEC disclosures | |
Roughly 54.0% of the company shares are held by company insiders | |
Latest headline from finance.yahoo.com: IceCure Medical to Report Third Quarter 2024 Financial Operational Results on November 26, 2024 |
Icecure Medical Upcoming and Recent Events
3rd of April 2024 Upcoming Quarterly Report | View | |
27th of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
3rd of April 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Icecure Largest EPS Surprises
Earnings surprises can significantly impact Icecure Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2024-08-20 | 2024-06-30 | -0.07 | -0.06 | 0.01 | 14 | ||
2023-08-14 | 2023-06-30 | -0.09 | -0.08 | 0.01 | 11 | ||
2023-05-22 | 2023-03-31 | -0.09 | -0.08 | 0.01 | 11 |
Icecure Stock Institutional Investors
Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Renaissance Technologies Corp | 2024-09-30 | 0.0 | Mather Group, Inc. | 2024-06-30 | 0.0 | Advisor Group Holdings, Inc. | 2024-06-30 | 0.0 | Hrt Financial Llc | 2024-06-30 | 0.0 | Citadel Advisors Llc | 2024-06-30 | 169.5 K | Virtu Financial Llc | 2024-06-30 | 27.2 K | Two Sigma Investments Llc | 2024-06-30 | 21.3 K | Foundations Investment Advisors, Llc | 2024-09-30 | 10 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 6.1 K | Jpmorgan Chase & Co | 2024-06-30 | 6 K | Efficient Wealth Management Llc | 2024-09-30 | 2.5 K |
Icecure Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 39.53 M.Icecure Profitablity
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.89) | (0.94) | |
Return On Capital Employed | (1.24) | (1.30) | |
Return On Assets | (0.89) | (0.94) | |
Return On Equity | (1.20) | (1.14) |
Management Efficiency
Icecure Medical has return on total asset (ROA) of (0.4736) % which means that it has lost $0.4736 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.9422) %, meaning that it created substantial loss on money invested by shareholders. Icecure Medical's management efficiency ratios could be used to measure how well Icecure Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of the 24th of November 2024, Return On Tangible Assets is likely to drop to -0.94. In addition to that, Return On Capital Employed is likely to drop to -1.3. At this time, Icecure Medical's Non Current Assets Total are very stable compared to the past year. As of the 24th of November 2024, Non Currrent Assets Other is likely to grow to about 67.8 K, while Total Current Assets are likely to drop about 11.8 M.Last Reported | Projected for Next Year | ||
Book Value Per Share | 0.27 | 0.25 | |
Tangible Book Value Per Share | 0.27 | 0.25 | |
Enterprise Value Over EBITDA | (2.55) | (2.68) | |
Price Book Value Ratio | 4.01 | 4.22 | |
Enterprise Value Multiple | (2.55) | (2.68) | |
Price Fair Value | 4.01 | 4.22 | |
Enterprise Value | 38.9 M | 37 M |
Icecure Medical showcases strong leadership that adapts to market changes and drives innovation. Our analysis explores how this adaptability affects the stock's investment appeal.
Operating Margin (3.19) | Beta 2.631 | Return On Assets (0.47) | Return On Equity (0.94) |
Technical Drivers
As of the 24th of November, Icecure Medical retains the Downside Deviation of 4.41, risk adjusted performance of 0.0339, and Market Risk Adjusted Performance of (1.39). Icecure Medical technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Icecure Medical standard deviation and the relationship between the treynor ratio and kurtosis to decide if Icecure Medical is priced fairly, providing market reflects its last-minute price of 0.71 per share. As Icecure Medical is a penny stock we also advise to confirm its total risk alpha numbers.Icecure Medical Price Movement Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Icecure Medical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Icecure Medical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Icecure Medical Outstanding Bonds
Icecure Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Icecure Medical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Icecure bonds can be classified according to their maturity, which is the date when Icecure Medical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Boeing Co 2196 Corp BondUS097023DG73 | View | |
HSBC Holdings PLC Corp BondUS404280DR76 | View | |
MGM Resorts International Corp BondUS552953CD18 | View | |
AerCap Global Aviation Corp BondUS00773HAA59 | View |
Icecure Medical Predictive Daily Indicators
Icecure Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Icecure Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Icecure Medical Forecast Models
Icecure Medical's time-series forecasting models are one of many Icecure Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Icecure Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Icecure Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Icecure Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Icecure shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Icecure Medical. By using and applying Icecure Stock analysis, traders can create a robust methodology for identifying Icecure entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | (4.54) | (4.76) | |
Operating Profit Margin | (4.82) | (5.06) | |
Net Loss | (4.54) | (4.76) | |
Gross Profit Margin | 0.40 | 0.28 |
Current Icecure Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Icecure analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Icecure analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
2.91 | Strong Buy | 3 | Odds |
Most Icecure analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Icecure stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Icecure Medical, talking to its executives and customers, or listening to Icecure conference calls.
Icecure Stock Analysis Indicators
Icecure Medical stock analysis indicators help investors evaluate how Icecure Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Icecure Medical shares will generate the highest return on investment. By understating and applying Icecure Medical stock analysis, traders can identify Icecure Medical position entry and exit signals to maximize returns.
Begin Period Cash Flow | 23.7 M | |
Common Stock Shares Outstanding | 45.6 M | |
Total Stockholder Equity | 12.2 M | |
Property Plant And Equipment Net | 2.2 M | |
Cash And Short Term Investments | 11.1 M | |
Cash | 10.5 M | |
Accounts Payable | 502 K | |
Net Debt | -9.9 M | |
50 Day M A | 0.6322 | |
Total Current Liabilities | 3.9 M | |
Other Operating Expenses | 18.8 M | |
Non Current Assets Total | 2.2 M | |
Non Currrent Assets Other | 34 K | |
Stock Based Compensation | 1.3 M |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Icecure Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Icecure Stock, please use our How to Invest in Icecure Medical guide.You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Icecure Medical. If investors know Icecure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Icecure Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.29) | Revenue Per Share 0.071 | Quarterly Revenue Growth 0.079 | Return On Assets (0.47) | Return On Equity (0.94) |
The market value of Icecure Medical is measured differently than its book value, which is the value of Icecure that is recorded on the company's balance sheet. Investors also form their own opinion of Icecure Medical's value that differs from its market value or its book value, called intrinsic value, which is Icecure Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Icecure Medical's market value can be influenced by many factors that don't directly affect Icecure Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Icecure Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Icecure Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Icecure Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.